Discovery of the Philadelphia chromosome: a personal perspective
about
Imatinib for treating newly diagnosed chronic myeloid leukemia patientsImatinib for treating patients with chronic myelogeneous leukemiaJanus kinases in immune cell signalingTargeting kinase signaling pathways with constrained peptide scaffolds.High-dose imatinib for newly diagnosed chronic phase chronic myeloid leukemia patients--systematic review and meta-analysis.New Insights in the Cytogenetic Practice: Karyotypic Chaos, Non-Clonal Chromosomal Alterations and Chromosomal Instability in Human Cancer and Therapy ResponseBUB3 that dissociates from BUB1 activates caspase-independent mitotic death (CIMD).Regulation of hTERT by BCR-ABL at multiple levels in K562 cells.Optimisation of tetrahydroisoquinoline-based chimeric microtubule disruptors.Detection of gene expression changes at chromosomal rearrangement breakpoints in evolutionIdentifying driver genes in cancer by triangulating gene expression, gene location, and survival data.JAK Kinases in Health and Disease: An UpdateThe legacy of the Philadelphia chromosome.A history of the discovery of random x chromosome inactivation in the human female and its significance.Translating insights from the cancer genome into clinical practiceGenomic and proteomic biomarkers for cancer: a multitude of opportunities.Severe toxicity of skin rash, fever and diarrhea associated with imatinib: case report and review of skin toxicities associated with tyrosine kinase inhibitors.The bone marrow microenvironment and leukemia: biology and therapeutic targeting.Evolving concepts of tumor heterogeneity.Adolescent and young adult patients with cancer: a milieu of unique features.Elucidating the cancer-specific genetic alteration spectrum of glioblastoma derived cell lines from whole exome and RNA sequencing.Korean Red Ginseng Extract Enhances the Anticancer Effects of Imatinib Mesylate Through Abrogation p38 and STAT5 Activation in KBM-5 Cells.Cardiovascular Complications of Targeted Therapies for Chronic Myeloid Leukemia.Synchronous Occurrence of Chronic Myeloid Leukemia and Mantle Cell Lymphoma.Imatinib causing drug rash with eosinophilia and systemic symptoms: A rare cutaneous reaction.Oxidative stress promotes transcriptional up-regulation of Fyn in BCR-ABL1-expressing cells.The Role of Centromere Defects in Cancer.Using Genome Sequence to Enable the Design of Medicines and Chemical Probes.Translocation Breakpoints Preferentially Occur in Euchromatin and Acrocentric Chromosomes.Identification of natural inhibitors of Bcr-Abl for the treatment of chronic myeloid leukemia.Targeted photodynamic therapy as potential treatment modality for the eradication of colon cancer and colon cancer stem cells.Mechanisms of receptor tyrosine kinase activation in cancer.Adherence to TKI in CML patients: more than reports.Novel IRF-1 Mutations in a Small Cohort of Leukaemia Patients From Saudi ArabiaOral Effects and Early Implant Survival Results After Imatinib Discontinuation Therapy for Chronic Myelogenous Leukemia: A Case Report.Inhibition of Ras-mediated signaling pathways in CML stem cells.Imatinib and beyond--targeting activated tyrosine kinases in myeloproliferative disorders.
P2860
Q24186877-AA2F19D4-570C-46F1-B682-7004EB41F903Q24241730-340CA6C1-9529-480A-8B34-B8F3AAFD072FQ24322021-541D6602-EFD1-4FEE-BF44-9A3C6F554665Q30398451-FB47A5B5-58B1-4E27-B005-4A2E41176F67Q33396265-6F328FB7-1D5F-4E37-AC4E-D59DC17E4711Q33836777-E8FD3D62-E362-4477-A683-5A1EE194783DQ33838181-08F01935-54E2-4FE4-8D00-B1042D391484Q34094028-A0CFE415-C562-4CF9-B1A8-CAF306C6C1B6Q34094248-12FC49E1-4A99-45F8-9E61-5D51D7B20783Q34247897-090038EC-2CC8-4F83-A759-47C6AF450A1EQ35623841-298D7FB5-1C4B-400D-997C-552483FF15B1Q36285745-47756F68-67B5-43DF-98B4-FC521CA261DEQ36900099-3BBD9FE8-7B5B-48B5-B48C-050FC7289D9EQ36919163-407604E0-C87D-4435-A94A-D38382D7E37CQ37127235-2EF23BF8-46AE-4AA9-BCB0-3EC32A15BFDEQ37363928-D79B5617-FB74-4574-8414-D420FF902ED1Q37385584-6CAB67ED-DF96-452C-B28C-9D1CC1C57DB5Q37888712-17910104-FFE6-467C-ABE3-1A220802C2F8Q38456932-AD7F154A-BE3E-4D96-B5B7-2FFD9D96F721Q38502885-A9F79B90-B1A7-42C4-A137-D823C9500B67Q38825589-70CD8A20-6722-47A2-A96F-A748B31BBA3FQ38889273-BA1085D6-2C75-4303-9CD0-E0D0FE71744BQ39186183-18481514-E3A7-4E20-ABCA-6DDE9386D319Q41890375-043F0365-BC85-4D18-906A-800D0909F27AQ42135221-84A1E12E-2FDF-4100-932B-AEC8538FC426Q42186300-1C20D02A-5F4A-4FDA-ABF1-E3A92E69C1DDQ47907691-5239728D-702B-4889-918D-07DE92E34555Q48263612-D12CE1DE-7417-426E-869A-EABE6F00ECD1Q48278237-ACDD8165-E46D-4B65-8ADF-95FE4CC8AA62Q48365472-731F7AAE-D6E6-4311-AD10-5CEEFA4EA213Q49486366-C7CDD763-80BB-4DC0-8E0B-DD65771A5870Q49888000-35DC9058-F5B9-42FD-B395-1EA7ABC97875Q49905088-2F92B8D3-C486-4568-917E-D970C3A17C6AQ50088467-D28F0D86-451B-4EAB-8FF0-28B114D655B5Q51733092-1B60AF46-33FC-4C5F-91E1-C725E4EE7855Q53314331-E0AE2949-C537-43CB-9C9C-1CA15D862F2EQ54533328-C7CA99E7-2B2C-4D7A-9630-B38C16BC089A
P2860
Discovery of the Philadelphia chromosome: a personal perspective
description
2007 nî lūn-bûn
@nan
2007 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2007 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2007年の論文
@ja
2007年学术文章
@wuu
2007年学术文章
@zh-cn
2007年学术文章
@zh-hans
2007年学术文章
@zh-my
2007年学术文章
@zh-sg
2007年學術文章
@yue
name
Discovery of the Philadelphia chromosome: a personal perspective
@ast
Discovery of the Philadelphia chromosome: a personal perspective
@en
Discovery of the Philadelphia chromosome: a personal perspective
@nl
type
label
Discovery of the Philadelphia chromosome: a personal perspective
@ast
Discovery of the Philadelphia chromosome: a personal perspective
@en
Discovery of the Philadelphia chromosome: a personal perspective
@nl
prefLabel
Discovery of the Philadelphia chromosome: a personal perspective
@ast
Discovery of the Philadelphia chromosome: a personal perspective
@en
Discovery of the Philadelphia chromosome: a personal perspective
@nl
P2860
P356
P1476
Discovery of the Philadelphia chromosome: a personal perspective
@en
P2093
Peter C Nowell
P2860
P304
P356
10.1172/JCI31771
P407
P577
2007-08-01T00:00:00Z